Atlas Trials

A Non-interventional,Observational Post Authorization Study of Patients With Multiple Myeloma Treated With Lenalidomide TR

Clinical trial NCT02387879 · UNKNOWN

Trial details

NCT number
NCT02387879
Sponsor
Celgene
Status
UNKNOWN
Study type
OBSERVATIONAL
Multiple Myeloma
Start date
2013-12-25
Primary completion
2021-12-31
Enrollment
500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.